Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Biopharmaceutical Innovation and Value

This article was originally published in RPM Report

Executive Summary

Bristol-Myers Squibb’s top US commercial executive reflects on the impact pharmaceutical innovation has had on patients, the importance of separating “true” innovators from bad actors in the pricing debate – and on the urgency to do even more to help patients as quickly as possible.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register